Search for: "Nuvasive Inc"
Results 41 - 60
of 107
Sort by Relevance
|
Sort by Date
12 Sep 2017, 9:26 am
Nuvasive, 842 F.3d at 1383(citing Bowman Transp., Inc. v. [read post]
18 Jul 2017, 9:58 pm
Cir. 2017)"; "In re Nuvasive (Fed. [read post]
3 Jul 2017, 8:16 am
Cir. 2017) (concludingthat the Board provided an inadequate analysis to providemeaningful appellate review); In re Nuvasive, Inc., 842F.3d 1376, 1384–85 (Fed. [read post]
27 Jun 2017, 5:45 pm
In re Nuvasive, Inc., 842F.3d 1376, 1382 (Fed. [read post]
16 Jun 2017, 7:40 pm
,Inc. v. [read post]
5 May 2017, 9:12 am
Inc.) [read post]
25 Apr 2017, 9:25 am
” In re NuVasive, Inc., 841 F.3d 966,973 (Fed. [read post]
27 Feb 2017, 4:55 pm
” In re Cree, Inc., 818 F.3d 694,698 n.2 (Fed. [read post]
14 Feb 2017, 12:26 pm
See In re NuVasive, Inc., 842 F.3d1376, 1381–82 (Fed. [read post]
8 Dec 2016, 9:23 pm
Patent No. 8,361,156 in an inter partes review instituted on a petition by Medtronic, Inc. [read post]
7 Dec 2016, 5:08 pm
by Dennis Crouch In re NuVasive (Fed. [read post]
7 Dec 2016, 2:31 pm
SeeCutsforth, Inc. v. [read post]
10 Nov 2016, 9:59 pm
Interestingly, in the In re NuVasive, Inc. opinion decided on November 9, 2016, the Federal Circuit reviewed the outcome of two IPR proceedings related to the same patent, U.S. [read post]
9 Aug 2016, 12:06 pm
Based on two petitions filed by NuVasive, Inc. [read post]
22 Jul 2016, 8:49 am
NuVasive, Inc. [read post]
28 Jun 2016, 6:41 am
NuVasive, Inc., No. 15-85 (Commil re-hash – mens rea requirement for inducement) 3. [read post]
7 Jun 2016, 5:22 pm
” Medtronic Sofamor Danek USA, Inc. v.NuVasive, Inc., 136 S. [read post]
3 Jun 2016, 9:55 am
NuVasive, Inc. [read post]
3 Jun 2016, 6:40 am
NuVasive, Inc., No. 15-85 (Commil re-hash – mens rea requirement for inducement) 3. [read post]
18 May 2016, 8:19 am
NuVasive, Inc., No. 15-85 (Commil re-hash – mens rea requirement for inducement) 3. [read post]